AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
CLADRIBINE in Tunisia
4 products registered with DPM — 0 active, 4 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MAVENCLAD Comprimé / 10mg | 22073041H | MERCK EUROPE B.V | expired | 8 Oct 2021 |
| MAVENCLAD Comprimé / 10mg | 22073043H | MERCK EUROPE B.V | expired | 8 Oct 2021 |
| MAVENCLAD Comprimé / 10mg | 22073042H | MERCK EUROPE B.V | expired | 8 Oct 2021 |
| LITAK Solution injectable / 10 mg (2mg/ml) | 12723011H | LIPOMED AG | expired | 9 Feb 2015 |
CLADRIBINE — DPM Registration Details
DPM (Tunisia) has 4 registered products containing CLADRIBINE, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track CLADRIBINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.